Skip to main content
SpringerLink
Log in

Neurosarcoidosis

  • Chapter
  • First Online:
Neurorheumatology

  • 1013 Accesses

Abstract

The protean manifestations of neurosarcoidosis (NS) make familiarity with its clinical, radiological, and biological spectra important for the astute clinician. A rational approach to the diagnosis and a thorough knowledge of the differential diagnosis is critical. No clinical trials in NS have been conducted to date, but treatment with glucocorticoids and steroid-sparing immunosuppressive agents is appropriate. Recent advances in management of NS include the use of tumor necrosis factor (TNF) inhibitors for aggressive or refractory cases.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Hunninghake GW, Costabel U, Ando M, Baughman R, Cordier JF, du Bois R, et al. ATS/ERS/WASOG statement on sarcoidosis. American thoracic society/European respiratory society/world association of sarcoidosis and other granulomatous disorders. Sarcoidosis Vasc Diffuse Lung Dis. 1999;16(2):149–73.

    CAS  PubMed  Google Scholar 

  2. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med. 2007;357(21):2153–65.

    Article  CAS  PubMed  Google Scholar 

  3. Rybicki BA, Iannuzzi MC. Epidemiology of sarcoidosis: recent advances and future prospects. Semin Respir Crit Care Med. 2007;28(1):22–35.

    Article  PubMed  Google Scholar 

  4. Bagnato F, Stern BJ. Neurosarcoidosis: diagnosis, therapy and biomarkers. Expert Rev Neurother. 2015;15(5):533–48.

    Article  CAS  PubMed  Google Scholar 

  5. Iwai K, Tachibana T, Takemura T, Matsui Y, Kitaichi M, Kawabata Y. Pathological studies on sarcoidosis autopsy. I. Epidemiological features of 320 cases in Japan. Acta Pathol Jpn. 1993;43(7–8):372–6.

    CAS  PubMed  Google Scholar 

  6. Stern BJ, Krumholz A, Johns C, Scott P, Nissim J. Sarcoidosis and its neurological manifestations. Arch Neurol. 1985;42(9):909–17.

    Article  CAS  PubMed  Google Scholar 

  7. Krumholz A, Stern BJ. Neurologic manifestations of sarcoidosis. In: Handbook of clinical neurology, vol. 119; 2014. p. 305–33.

    Google Scholar 

  8. Oksanen V. Neurosarcoidosis: clinical presentations and course in 50 patients. Acta Neurol Scand. 1986;73(3):283–90.

    Article  CAS  PubMed  Google Scholar 

  9. Zajicek JP, Scolding NJ, Foster O, Rovaris M, Evanson J, Moseley IF, et al. Central nervous system sarcoidosis–diagnosis and management. QJM. 1999;92(2):103–17.

    Article  CAS  PubMed  Google Scholar 

  10. Scott TF, Yandora K, Valeri A, Chieffe C, Schramke C. Aggressive therapy for neurosarcoidosis: long-term follow-up of 48 treated patients. Arch Neurol. 2007;64(5):691–6.

    Article  PubMed  Google Scholar 

  11. Ferriby D, de Seze J, Stojkovic T, Hachulla E, Wallaert B, Destee A, et al. Long-term follow-up of neurosarcoidosis. Neurology. 2001;57(5):927–9.

    Article  CAS  PubMed  Google Scholar 

  12. Carlson ML, White JR Jr, Espahbodi M, Haynes DS, Driscoll CL, Aksamit AJ, et al. Cranial base manifestations of neurosarcoidosis: a review of 305 patients. Otol Neurotol: official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology. 2015;36(1):156–66.

    Google Scholar 

  13. Tavee JO, Stern BJ. Neurosarcoidosis. Clin Chest Med. 2015;36(4):643–56.

    Article  PubMed  Google Scholar 

  14. Pawate S, Moses H, Sriram S. Presentations and outcomes of neurosarcoidosis: a study of 54 cases. QJM. 2009;102(7):449–60.

    Article  CAS  PubMed  Google Scholar 

  15. Hoitsma E, Faber CG, Drent M, Sharma OP. Neurosarcoidosis: a clinical dilemma. Lancet Neurol. 2004;3(7):397–407.

    Article  PubMed  Google Scholar 

  16. Terushkin V, Stern BJ, Judson MA, Hagiwara M, Pramanik B, Sanchez M, et al. Neurosarcoidosis: presentations and management. Neurologist. 2010;16(1):2–15.

    Article  PubMed  Google Scholar 

  17. Hickman SJ. Optic perineuritis. Curr Neurol Neurosci Rep. 2016;16(2):16.

    Article  PubMed  Google Scholar 

  18. Luke RA, Stern BJ, Krumholz A, Johns CJ. Neurosarcoidosis: the long-term clinical course. Neurology. 1987;37(3):461–3.

    Article  CAS  PubMed  Google Scholar 

  19. Colvin IB. Audiovestibular manifestations of sarcoidosis: a review of the literature. Laryngoscope. 2006;116(1):75–82.

    Article  CAS  PubMed  Google Scholar 

  20. Murialdo G, Tamagno G. Endocrine aspects of neurosarcoidosis. J Endocrinol Investig. 2002;25(7):650–62.

    Article  CAS  Google Scholar 

  21. Nowak DA, Widenka DC. Neurosarcoidosis: a review of its intracranial manifestation. J Neurol. 2001;248(5):363–72.

    Article  CAS  PubMed  Google Scholar 

  22. Lury KM, Smith JK, Matheus MG, Castillo M. Neurosarcoidosis–review of imaging findings. Semin Roentgenol. 2004;39(4):495–504.

    Article  PubMed  Google Scholar 

  23. Macedo PJ, da Silveira VC, Ramos LT, Nobrega FR, Vasconcellos LF. Isolated central nervous system vasculitis as a manifestation of neurosarcoidosis. J Stroke Cerebrovasc Dis. 2016;25(6):e89–92.

    Article  PubMed  Google Scholar 

  24. Brown MM, Thompson AJ, Wedzicha JA, Swash M. Sarcoidosis presenting with stroke. Stroke. 1989;20(3):400–5.

    Article  CAS  PubMed  Google Scholar 

  25. Spiegel DR, Morris K, Rayamajhi U. Neurosarcoidosis and the complexity in its differential diagnoses: a review. Innov Clin Neurosci. 2012;9(4):10–6.

    PubMed  PubMed Central  Google Scholar 

  26. Ginat DT, Dhillon G, Almast J. Magnetic resonance imaging of neurosarcoidosis. J Clin Imaging Sci. 2011;1:15.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Joubert B, Chapelon-Abric C, Biard L, Saadoun D, Demeret S, Dormont D, et al. Association of prognostic factors and immunosuppressive treatment with long-term outcomes in neurosarcoidosis. JAMA Neurol. 2017;74(11):1336–44.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Junger SS, Stern BJ, Levine SR, Sipos E, Marti-Masso JF. Intramedullary spinal sarcoidosis: clinical and magnetic resonance imaging characteristics. Neurology. 1993;43(2):333–7.

    Article  CAS  PubMed  Google Scholar 

  29. Hashmi M, Kyritsis AP. Diagnosis and treatment of intramedullary spinal cord sarcoidosis. J Neurol. 1998;245(3):178–80.

    Article  CAS  PubMed  Google Scholar 

  30. Smith JK, Matheus MG, Castillo M. Imaging manifestations of neurosarcoidosis. AJR Am J Roentgenol. 2004;182(2):289–95.

    Article  PubMed  Google Scholar 

  31. Flanagan EP, Kaufmann TJ, Krecke KN, Aksamit AJ, Pittock SJ, Keegan BM, et al. Discriminating long myelitis of neuromyelitis optica from sarcoidosis. Ann Neurol. 2016;79(3):437–47.

    Article  PubMed  Google Scholar 

  32. Zalewski NL, Krecke KN, Weinshenker BG, Aksamit AJ, Conway BL, McKeon A, et al. Central canal enhancement and the trident sign in spinal cord sarcoidosis. Neurology. 2016;87(7):743–4.

    Article  PubMed  Google Scholar 

  33. Zuniga G, Ropper AH, Frank J. Sarcoid peripheral neuropathy. Neurology. 1991;41(10):1558–61.

    Article  CAS  PubMed  Google Scholar 

  34. Burns TM, Dyck PJ, Aksamit AJ, Dyck PJ. The natural history and long-term outcome of 57 limb sarcoidosis neuropathy cases. J Neurol Sci. 2006;244(1–2):77–87.

    Article  CAS  PubMed  Google Scholar 

  35. Vital A, Lagueny A, Ferrer X, Louiset P, Canron MH, Vital C. Sarcoid neuropathy: clinico-pathological study of 4 new cases and review of the literature. Clin Neuropathol. 2008;27(2):96–105.

    Article  CAS  PubMed  Google Scholar 

  36. Heij L, Dahan A, Hoitsma E. Sarcoidosis and pain caused by small-fiber neuropathy. Pain Res Treat. 2012;2012:256024.

    PubMed  PubMed Central  Google Scholar 

  37. Wong JC, Sparks JA, Doyle TJ, Paulson VA, Milligan TA, Prasad S. Systemic sarcoidosis presenting as harlequin and horner syndrome. Neurol Clin Pract. 2015;5(6):524–7.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Tavee J, Culver D. Sarcoidosis and small-fiber neuropathy. Curr Pain Headache Rep. 2011;15(3):201–6.

    Article  PubMed  Google Scholar 

  39. Ungprasert P, Carmona EM, Crowson CS, Matteson EL. Diagnostic utility of angiotensin-converting enzyme in sarcoidosis: a population-based study. Lung. 2016;194(1):91–5.

    Article  CAS  PubMed  Google Scholar 

  40. Bridel C, Courvoisier DS, Vuilleumier N, Lalive PH. Cerebrospinal fluid angiotensin-converting enzyme for diagnosis of neurosarcoidosis. J Neuroimmunol. 2015;285:1–3.

    Article  CAS  PubMed  Google Scholar 

  41. Lexa FJ, Grossman RI. MR of sarcoidosis in the head and spine: spectrum of manifestations and radiographic response to steroid therapy. AJNR Am J Neuroradiol. 1994;15(5):973–82.

    CAS  PubMed  Google Scholar 

  42. Bathla G, Singh AK, Policeni B, Agarwal A, Case B. Imaging of neurosarcoidosis: common, uncommon, and rare. Clin Radiol. 2016;71(1):96–106.

    Article  CAS  PubMed  Google Scholar 

  43. Teirstein AS, Machac J, Almeida O, Lu P, Padilla ML, Iannuzzi MC. Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis. Chest. 2007;132(6):1949–53.

    Article  PubMed  Google Scholar 

  44. Rossi G, Cavazza A, Colby TV. Pathology of sarcoidosis. Clin Rev Allergy Immunol. 2015;49(1):36–44.

    Article  CAS  PubMed  Google Scholar 

  45. Nakajima T, Yasufuku K, Fujiwara T, Yoshino I. Recent advances in endobronchial ultrasound-guided transbronchial needle aspiration. Respir Investig. 2016;54(4):230–6.

    Article  PubMed  Google Scholar 

  46. Agbogu BN, Stern BJ, Sewell C, Yang G. Therapeutic considerations in patients with refractory neurosarcoidosis. Arch Neurol. 1995;52(9):875–9.

    Article  CAS  PubMed  Google Scholar 

  47. Stern BJ, Aksamit A, Clifford D, Scott TF, Neurosarcoidosis Study G. Neurologic presentations of sarcoidosis. Neurol Clin. 2010;28(1):185–98.

    Article  PubMed  Google Scholar 

  48. Fritz D, van de Beek D, Brouwer MC. Clinical features, treatment and outcome in neurosarcoidosis: systematic review and meta-analysis. BMC Neurol. 2016;16(1):220.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Nozaki K, Judson MA. Neurosarcoidosis. Curr Treat Options Neurol. 2013;15(4):492–504.

    Article  PubMed  Google Scholar 

  50. Lorentzen AO, Sveberg L, Midtvedt O, Kerty E, Heuser K. Overnight response to infliximab in neurosarcoidosis: a case report and review of infliximab treatment practice. Clin Neuropharmacol. 2014;37(5):142–8.

    Article  CAS  PubMed  Google Scholar 

  51. Riancho-Zarrabeitia L, Delgado-Alvarado M, Riancho J, Oterino A, Sedano MJ, Rueda-Gotor J, et al. Anti-TNF-alpha therapy in the management of severe neurosarcoidosis: a report of five cases from a single centre and literature review. Clin Exp Rheumatol. 2014;32(2):275–84.

    CAS  PubMed  Google Scholar 

  52. Lower EE, Broderick JP, Brott TG, Baughman RP. Diagnosis and management of neurological sarcoidosis. Arch Intern Med. 1997;157(16):1864–8.

    Article  CAS  PubMed  Google Scholar 

  53. Androdias G, Maillet D, Marignier R, Pinede L, Confavreux C, Broussolle C, et al. Mycophenolate mofetil may be effective in CNS sarcoidosis but not in sarcoid myopathy. Neurology. 2011;76(13):1168–72.

    Article  CAS  PubMed  Google Scholar 

  54. Sharma OP. Effectiveness of chloroquine and hydroxychloroquine in treating selected patients with sarcoidosis with neurological involvement. Arch Neurol. 1998;55(9):1248–54.

    Article  CAS  PubMed  Google Scholar 

  55. Bitoun S, Bouvry D, Borie R, Mahevas M, Sacre K, Haroche J, et al. Treatment of neurosarcoidosis: a comparative study of methotrexate and mycophenolate mofetil. Neurology. 2016;87(24):2517–21.

    Article  CAS  PubMed  Google Scholar 

  56. Iannuzzi MC, Fontana JR. Sarcoidosis: clinical presentation, immunopathogenesis, and therapeutics. JAMA. 2011;305(4):391–9.

    Article  CAS  PubMed  Google Scholar 

  57. Baughman RP, Lower EE. Treatment of sarcoidosis. Clin Rev Allergy Immunol. 2015;49(1):79–92.

    Article  CAS  PubMed  Google Scholar 

  58. Marnane M, Lynch T, Scott J, Stack J, Kelly PJ. Steroid-unresponsive neurosarcoidosis successfully treated with adalimumab. J Neurol. 2009;256(1):139–40.

    Article  PubMed  Google Scholar 

  59. Decock A, Van Assche G, Vermeire S, Wuyts W, Ferrante M. Sarcoidosis-like lesions: another paradoxical reaction to anti-TNF therapy? J Crohns Colitis. 2016;11(3):378–83.

    Google Scholar 

  60. Baughman RP, Drent M, Kavuru M, Judson MA, Costabel U, du Bois R, et al. Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med. 2006;174(7):795–802.

    Article  CAS  PubMed  Google Scholar 

  61. Rossman MD, Newman LS, Baughman RP, Teirstein A, Weinberger SE, Miller W Jr, et al. A double-blinded, randomized, placebo-controlled trial of infliximab in subjects with active pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2006;23(3):201–8.

    PubMed  Google Scholar 

  62. Bradshaw MJGJ, Stern B, Clifford DB, Wang Y, Cho TA, Vu N, Sriram S, Moses H, Bagnato F, Koth LL, Hauser SL, Dierkhising J, Kaufmann JA, Ammah D, Yohannes TH, Hamblin MJ, Venna N, Green AJ, Pawate S. Infliximab for the treatment of neurosarcoidosis: a multi-institutional case series. Neurology. 2017;88(16):Supplement P1.335.

    Google Scholar 

  63. Gelfand JM, Bradshaw MJ, Stern BJ, Clifford DB, Wang Y, Cho TA, et al. Infliximab for the treatment of CNS sarcoidosis: a multi-institutional series. Neurology. 2017;89:2092.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Bradshaw MJ, Mobley BC, Zwerner JP, Sriram S. Autopsy-proven demyelination associated with infliximab treatment. Neurol Neuroimmunol Neuroinflamm. 2016;2016:3(2).

    Google Scholar 

  65. Cathcart S, Sami N, Elewski B. Sarcoidosis as an adverse effect of tumor necrosis factor inhibitors. J Drugs Dermatol: JDD. 2012;11(5):609–12.

    CAS  PubMed  Google Scholar 

  66. Stern BJ, Royal W, Gelfand J, et al. Definition and Consensus Diagnostic Criteria for Neurosarcoidosis. JAMA Neurol. 2018;75(12):1546-1553.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Billings Clinic, Billings, MT, USA

    Michael J. Bradshaw

  2. Department of Neurology, Vanderbilt University Medical Center, Nashville, TN, USA

    Siddharama Pawate

  3. Department of Medicine, Harvard Medical School, Boston, MA, USA

    Jeffrey A. Sparks

  4. Department of Medicine, Division of Rheumatology, Immunology and Allergy, Brigham and Women’s Hospital, Boston, MA, USA

    Jeffrey A. Sparks

Authors
  1. Michael J. Bradshaw
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Siddharama Pawate
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jeffrey A. Sparks
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jeffrey A. Sparks .

Editor information

Editors and Affiliations

  1. Division of Neuroimmunology, University of Iowa, Iowa City, IA, USA

    Tracey A. Cho

  2. Department of Neurology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA

    Shamik Bhattacharyya

  3. Division of Rheumatology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA

    Simon Helfgott

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Bradshaw, M.J., Pawate, S., Sparks, J.A. (2019). Neurosarcoidosis. In: Cho, T., Bhattacharyya, S., Helfgott, S. (eds) Neurorheumatology. Springer, Cham. https://doi.org/10.1007/978-3-030-16928-2_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-16928-2_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-16927-5

  • Online ISBN: 978-3-030-16928-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation